Pharmaceutical Technology

SEPTEMBER 30, 2022

After several setbacks, bluebird bio bounces back with two major FDA gene therapy approvals. Last month, Zynteglo (betibeglogene autotemcel), or beti-cel, was approved as a one-time potentially curative gene therapy for patients with beta-thalassaemia who require regular blood transfusions.

FDA 115

FDA Insurance Patients Marketing 115

World of DTC Marketing

JUNE 23, 2021

One agency FDA adviser, resigning from his committee post in protest, called it “probably the worst drug approval decision in recent U.S. Biogen’s Aduhelm won FDA approval after discovering that some patients on higher dosages had displayed improvement of.39 Not to mention the $56,000 annual price tag.

FDA 218

FDA Side effects Physicians Patients 218

PM360

NOVEMBER 27, 2023

The first solution, developed by EVERSANA leveraging AWS and AWS Partner TensorIoT , addresses a time-consuming and error-prone process in the industry—medical and regulatory content approvals. The complexity of this process across healthcare is a primary barrier to delivering personalized and timely customer experiences.

Medical 52

Medical Education Healthcare Healthcare 52

PM360

OCTOBER 13, 2023

Another capability made possible by fine-tuning is the enhancement of content tagging. Content tagging has always been a labor-intensive task. Auto-tagging ensures that the right content efficiently reaches the right customers. For example, let’s consider approved email templates and key messages.

Marketing 64

Marketing Specialization Healthcare Healthcare 64

PM360

JUNE 26, 2023

Accelerated Content Creation and Organization Personalized engagement is crucial for successful commercialization, especially as more physicians have come to expect it from their online interactions as consumers. Auto-tagging, a laborious task, is another area where generative AI/LLMs can assist.

Pharma 97

Pharma Management Ethics Medical science 97

World of DTC Marketing

DECEMBER 13, 2021

As cancer survival rates rise, so do the price tags of life-saving treatments. 11 of the 12 cancer drugs that the Food and Drug Administration approved in 2012 were priced at more than $100,000 per year. OPENING: American cancer patients spent more than $21 billion on their care in 2019. billion included out-of-pocket costs of $16.22

Food and Drug Administration 55

Food and Drug Administration Food Medical Medicine 55

Pharmaceutical Technology

JUNE 29, 2022

For example, while orphan drug designations have more than doubled in the last decade compared to the previous one, only 16% of therapies with orphan tags have managed to gain FDA approval in some indications. Prior to the program, only 10 drugs were approved for a rare disease.

Food and Drug Administration 98

Food and Drug Administration FDA Marketing Pharmaceutical 98